BASFs, Restructuring

BASF's Restructuring Strategy Faces Market Skepticism

11.03.2026 - 04:24:50 | boerse-global.de

BASF lowers 2026 profit forecast, ramps up share buybacks and deep cost cuts to counter weak demand and geopolitical risks, while maintaining dividend.

BASF's Restructuring Strategy Faces Market Skepticism - Foto: über boerse-global.de
BASF's Restructuring Strategy Faces Market Skepticism - Foto: über boerse-global.de

The world's largest chemical company is undergoing a profound transformation. As it directs billions toward repurchasing its own shares, management has significantly tempered profit expectations for the current year. This raises a critical question: can stringent cost discipline effectively counterbalance weak demand and persistent geopolitical risks?

Shareholder Returns Provide a Counterbalance

Despite the subdued operational outlook, BASF continues to channel substantial capital back to its investors. In just the first week of March, the company bought back over 3.5 million of its own shares as part of an ongoing program. Furthermore, the dividend is expected to hold steady at 2.25 euros per share, with an ex-dividend date scheduled for May 4, 2026.

Sustaining these shareholder returns through internally generated cash flow is now a key imperative for management. Achieving this hinges on two critical factors: the free cash flow must land within the targeted corridor of 1.5 to 2.3 billion euros this year, and the ambitious cost-saving goal must be rigorously executed.

Revised Forecasts Disappoint Analysts

BASF's leadership has provided an operational earnings (EBITDA before special items) forecast for 2026 ranging between 6.2 and 7.0 billion euros. The midpoint of this guidance, at 6.6 billion, falls notably short of the approximately 7.0 billion euros that market analysts had previously anticipated. CEO Markus Kamieth indicated he does not foresee a near-term economic recovery or a de-escalation of geopolitical tensions in the immediate future.

The company anticipates a decline in chemical production, particularly in its European and North American markets. Additional headwinds stem from potential shifts in U.S. trade policy and a weak U.S. dollar, which alone could reduce first-quarter results by up to 200 million euros. The Asian segment, supported by steady Chinese export demand, remains a relative bright spot.

Should investors sell immediately? Or is it worth buying BASF?

Deep Cost Cuts and Portfolio Reshaping

In response to these macroeconomic pressures, BASF is intensifying its savings initiative. The goal is now to reduce annual costs by 2.3 billion euros by the end of 2026. To achieve this, the firm is cutting additional positions in administration and IT, while relocating certain functions to more cost-efficient locations in India and Malaysia.

Concurrently, the portfolio restructuring is advancing. The sale of the coatings business to financial investor Carlyle is slated for completion in the second quarter. Capital expenditures are also being scaled back, with a planned reduction of 20% by 2029.

The market has responded cautiously to this challenging transition. Shares closed recently at 45.78 euros, trading slightly below their 50-day moving average and showing a decline of nearly six percent over a 30-day period.

Ad

BASF Stock: New Analysis - 11 March

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

So schätzen die Börsenprofis BASFs Aktien ein!

<b>So schätzen die Börsenprofis  BASFs Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | DE000BASF111 | BASFS | boerse | 68657683 |